☆ 4.7 Letter

Durable responses to Erlotinib despite KRAS mutations in two patients with metastatic lung adenocarcinoma

ANNALS OF ONCOLOGY (2010)

Get Full Text
Add to Collection

Journal

ANNALS OF ONCOLOGY
Volume 21, Issue 6, Pages 1385-1387

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdq153

Keywords

-

Categories

Oncology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.